Global and Japan Beta-lactam and Beta-lactamase Inhibitors Market Size, Status and Forecast 2021-2027
Summary
Market Analysis and Insights: Global and Japan Beta-lactam and Beta-lactamase Inhibitors Market
This report focuses on global and Japan Beta-lactam and Beta-lactamase Inhibitors market.
In 2020, the global Beta-lactam and Beta-lactamase Inhibitors market size was US$ 23715 million and it is expected to reach US$ 31774 million by the end of 2027, with a CAGR of 1.93% during 2021-2027. In Japan the Beta-lactam and Beta-lactamase Inhibitors market size is expected to grow from US$ 2023 million in 2020 to US$ 2804 million by 2027, at a CAGR of 2.44% during the forecast period.
Global Beta-lactam and Beta-lactamase Inhibitors Scope and Market Size
Beta-lactam and Beta-lactamase Inhibitors market is segmented by region (country), by players, by Type, and by Application. Players, stakeholders, and other participants in the global Beta-lactam and Beta-lactamase Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
For Japan market, this report focuses on the Beta-lactam and Beta-lactamase Inhibitors market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.
By Company
Pfizer
Novartis (Sandoz)
TEVA
Merck
AbbVie (Allergan)
Sumitomo Dainippon
Hikma
Aurobindo Pharma
Wockhardt
Lupin Limited
Fresenius Kabi
B. Braun
USantibiotics
Qilu Pharmaceutical
ACS Dobfar
Nichi-Iko (Sagent)
Antibiotice
Segment by Type
Penicillins
Cephalosporins
Carbapenems
Monobactams
Segment by Application
Oral
Intravenous
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
- 1 STUDY COVERAGE
- 1.1 Beta-lactam and Beta-lactamase Inhibitors Product Introduction
- 1.2 Market by Type
- 1.2.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth Rate by Type
- 1.2.2 Penicillins
- 1.2.3 Cephalosporins
- 1.2.4 Carbapenems
- 1.2.5 Monobactams
- 1.3 Market by Application
- 1.3.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth Rate by Application
- 1.3.2 Oral
- 1.3.3 Intravenous
- 1.4 Study Objectives
- 1.5 Years Considered
- 2 EXECUTIVE SUMMARY
- 2.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size Estimates and Forecasts
- 2.1.1 Global Beta-lactam and Beta-lactamase Inhibitors Revenue 2016-2027
- 2.1.2 Global Beta-lactam and Beta-lactamase Inhibitors Sales 2016-2027
- 2.2 Beta-lactam and Beta-lactamase Inhibitors Market Size by Region: 2016 VS 2021 VS 2027
- 2.3 Beta-lactam and Beta-lactamase Inhibitors Historical Market Size by Region (2016-2027)
- 2.3.1 Global Beta-lactam and Beta-lactamase Inhibitors Retrospective Market Scenario in Sales by Region: 2016-2021
- 2.3.2 Global Beta-lactam and Beta-lactamase Inhibitors Retrospective Market Scenario in Revenue by Region: 2016-2021
- 2.4 Beta-lactam and Beta-lactamase Inhibitors Market Estimates and Projections by Region (2022-2027)
- 2.4.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales Forecast by Region (2022-2027)
- 2.4.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue Forecast by Region (2022-2027)
- 3 GLOBAL BETA-LACTAM AND BETA-LACTAMASE INHIBITORS COMPETITOR LANDSCAPE BY PLAYERS
- 3.1 Global Top Beta-lactam and Beta-lactamase Inhibitors Manufacturers by Sales
- 3.1.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales by Manufacturer (2016-2021)
- 3.1.2 Global Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Manufacturer (2016-2021)
- 3.2 Global Top Beta-lactam and Beta-lactamase Inhibitors Manufacturers by Revenue
- 3.2.1 Key Beta-lactam and Beta-lactamase Inhibitors Manufacturers Covered: Ranking by Revenue
- 3.2.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Manufacturer (2016-2021)
- 3.2.3 Global Beta-lactam and Beta-lactamase Inhibitors Revenue Share by Manufacturer (2016-2021)
- 3.2.4 Global Beta-lactam and Beta-lactamase Inhibitors Market Concentration Ratio (CR5 and HHI) & (2016-2021)
- 3.2.5 Global Top 10 and Top 5 Companies by Beta-lactam and Beta-lactamase Inhibitors Revenue in 2020
- 3.2.6 Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Global Beta-lactam and Beta-lactamase Inhibitors Price by Manufacturer (2016-2021)
- 3.4 Global Beta-lactam and Beta-lactamase Inhibitors Manufacturing Base Distribution, Product Type
- 3.4.1 Beta-lactam and Beta-lactamase Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Beta-lactam and Beta-lactamase Inhibitors Product Type
- 3.4.3 Date of International Manufacturers Enter into Beta-lactam and Beta-lactamase Inhibitors Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
- 4 BREAKDOWN DATA BY TYPE (2016-2027)
- 4.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021)
- 4.1.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2016-2021)
- 4.1.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Type (2016-2021)
- 4.1.3 Beta-lactam and Beta-lactamase Inhibitors Average Selling Price (ASP) by Type (2016-2021)
- 4.2 Global Beta-lactam and Beta-lactamase Inhibitors Market Size Forecast by Type (2022-2027)
- 4.2.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales Forecast by Type (2022-2027)
- 4.2.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue Forecast by Type (2022-2027)
- 4.2.3 Global Beta-lactam and Beta-lactamase Inhibitors Average Selling Price (ASP) Forecast by Type (2022-2027)
- 5 BREAKDOWN DATA BY APPLICATION (2016-2027)
- 5.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021)
- 5.1.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2016-2021)
- 5.1.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Application (2016-2021)
- 5.1.3 Beta-lactam and Beta-lactamase Inhibitors Price by Application (2016-2021)
- 5.2 Beta-lactam and Beta-lactamase Inhibitors Market Size Forecast by Application (2022-2027)
- 5.2.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales Forecast by Application (2022-2027)
- 5.2.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue Forecast by Application (2022-2027)
- 5.2.3 Global Beta-lactam and Beta-lactamase Inhibitors Price Forecast by Application (2022-2027)
- 6 JAPAN BY PLAYERS, BY TYPE AND BY APPLICATION
- 6.1 Japan Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth 2016-2027
- 6.1.1 Japan Beta-lactam and Beta-lactamase Inhibitors Sales YoY Growth 2016-2027
- 6.1.2 Japan Beta-lactam and Beta-lactamase Inhibitors Revenue YoY Growth 2016-2027
- 6.1.3 Japan Beta-lactam and Beta-lactamase Inhibitors Market Share in Global Market 2016-2027
- 6.2 Japan Beta-lactam and Beta-lactamase Inhibitors Market Size by Players (International and Local Players)
- 6.2.1 Japan Top Beta-lactam and Beta-lactamase Inhibitors Players by Sales (2016-2021)
- 6.2.2 Japan Top Beta-lactam and Beta-lactamase Inhibitors Players by Revenue (2016-2021)
- 6.3 Japan Beta-lactam and Beta-lactamase Inhibitors Historic Market Review by Type (2016-2021)
- 6.3.1 Japan Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Type (2016-2021)
- 6.3.2 Japan Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Type (2016-2021)
- 6.3.3 Japan Beta-lactam and Beta-lactamase Inhibitors Price by Type (2016-2021)
- 6.4 Japan Beta-lactam and Beta-lactamase Inhibitors Market Estimates and Forecasts by Type (2022-2027)
- 6.4.1 Japan Beta-lactam and Beta-lactamase Inhibitors Sales Forecast by Type (2022-2027)
- 6.4.2 Japan Beta-lactam and Beta-lactamase Inhibitors Revenue Forecast by Type (2022-2027)
- 6.4.3 Japan Beta-lactam and Beta-lactamase Inhibitors Price Forecast by Type (2022-2027)
- 6.5 Japan Beta-lactam and Beta-lactamase Inhibitors Historic Market Review by Application (2016-2021)
- 6.5.1 Japan Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Application (2016-2021)
- 6.5.2 Japan Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Application (2016-2021)
- 6.5.3 Japan Beta-lactam and Beta-lactamase Inhibitors Price by Application (2016-2021)
- 6.6 Japan Beta-lactam and Beta-lactamase Inhibitors Market Estimates and Forecasts by Application (2022-2027)
- 6.6.1 Japan Beta-lactam and Beta-lactamase Inhibitors Sales Forecast by Application (2022-2027)
- 6.6.2 Japan Beta-lactam and Beta-lactamase Inhibitors Revenue Forecast by Application (2022-2027)
- 6.6.3 Japan Beta-lactam and Beta-lactamase Inhibitors Price Forecast by Application (2022-2027)
- 7 NORTH AMERICA
- 7.1 North America Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth 2016-2027
- 7.2 North America Beta-lactam and Beta-lactamase Inhibitors Market Facts & Figures by Country
- 7.2.1 North America Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2016-2021)
- 7.2.2 North America Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2021)
- 7.2.3 U.S.
- 7.2.4 Canada
- 8 ASIA-PACIFIC
- 8.1 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth 2016-2027
- 8.2 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Facts & Figures by Region
- 8.2.1 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Sales by Region (2016-2021)
- 8.2.2 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Revenue by Region (2016-2021)
- 8.2.3 China
- 8.2.4 Japan
- 8.2.5 South Korea
- 8.2.6 India
- 8.2.7 Australia
- 8.2.8 Indonesia
- 8.2.9 Thailand
- 8.2.10 Malaysia
- 8.2.11 Philippines
- 9 EUROPE
- 9.1 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth 2016-2027
- 9.2 Europe Beta-lactam and Beta-lactamase Inhibitors Market Facts & Figures by Country
- 9.2.1 Europe Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2016-2021)
- 9.2.2 Europe Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2021)
- 9.2.3 Germany
- 9.2.4 France
- 9.2.5 U.K.
- 9.2.6 Italy
- 9.2.7 Russia
- 10 LATIN AMERICA
- 10.1 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth 2016-2027
- 10.2 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Facts & Figures by Country
- 10.2.1 Latin America Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2016-2021)
- 10.2.2 Latin America Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2021)
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
- 11 MIDDLE EAST AND AFRICA
- 11.1 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth 2016-2027
- 11.2 Middle East and Africa Beta-lactam and Beta-lactamase Inhibitors Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2016-2021)
- 11.2.2 Middle East and Africa Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2021)
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 UAE
- 12 COMPANY PROFILES
- 12.1 Pfizer
- 12.1.1 Pfizer Corporation Information
- 12.1.2 Pfizer Description and Business Overview
- 12.1.3 Pfizer Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
- 12.1.4 Pfizer Beta-lactam and Beta-lactamase Inhibitors Products Offered
- 12.2 Novartis (Sandoz)
- 12.2.1 Novartis (Sandoz) Corporation Information
- 12.2.2 Novartis (Sandoz) Description and Business Overview
- 12.2.3 Novartis (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
- 12.2.4 Novartis (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Products Offered
- 12.3 TEVA
- 12.3.1 TEVA Corporation Information
- 12.3.2 TEVA Description and Business Overview
- 12.3.3 TEVA Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
- 12.3.4 TEVA Beta-lactam and Beta-lactamase Inhibitors Products Offered
- 12.4 Merck
- 12.4.1 Merck Corporation Information
- 12.4.2 Merck Description and Business Overview
- 12.4.3 Merck Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
- 12.4.4 Merck Beta-lactam and Beta-lactamase Inhibitors Products Offered
- 12.5 AbbVie (Allergan)
- 12.5.1 AbbVie (Allergan) Corporation Information
- 12.5.2 AbbVie (Allergan) Description and Business Overview
- 12.5.3 AbbVie (Allergan) Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
- 12.5.4 AbbVie (Allergan) Beta-lactam and Beta-lactamase Inhibitors Products Offered
- 12.6 Sumitomo Dainippon
- 12.6.1 Sumitomo Dainippon Corporation Information
- 12.6.2 Sumitomo Dainippon Description and Business Overview
- 12.6.3 Sumitomo Dainippon Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
- 12.6.4 Sumitomo Dainippon Beta-lactam and Beta-lactamase Inhibitors Products Offered
- 12.7 Hikma
- 12.7.1 Hikma Corporation Information
- 12.7.2 Hikma Description and Business Overview
- 12.7.3 Hikma Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
- 12.7.4 Hikma Beta-lactam and Beta-lactamase Inhibitors Products Offered
- 12.8 Aurobindo Pharma
- 12.8.1 Aurobindo Pharma Corporation Information
- 12.8.2 Aurobindo Pharma Description and Business Overview
- 12.8.3 Aurobindo Pharma Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
- 12.8.4 Aurobindo Pharma Beta-lactam and Beta-lactamase Inhibitors Products Offered
- 12.9 Wockhardt
- 12.9.1 Wockhardt Corporation Information
- 12.9.2 Wockhardt Description and Business Overview
- 12.9.3 Wockhardt Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
- 12.9.4 Wockhardt Beta-lactam and Beta-lactamase Inhibitors Products Offered
- 12.10 Lupin Limited
- 12.10.1 Lupin Limited Corporation Information
- 12.10.2 Lupin Limited Description and Business Overview
- 12.10.3 Lupin Limited Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
- 12.10.4 Lupin Limited Beta-lactam and Beta-lactamase Inhibitors Products Offered
- 12.11 Fresenius Kabi
- 12.11.1 Fresenius Kabi Corporation Information
- 12.11.2 Fresenius Kabi Description and Business Overview
- 12.11.3 Fresenius Kabi Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
- 12.11.4 Fresenius Kabi Beta-lactam and Beta-lactamase Inhibitors Products Offered
- 12.12 B. Braun
- 12.12.1 B. Braun Corporation Information
- 12.12.2 B. Braun Description and Business Overview
- 12.12.3 B. Braun Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
- 12.12.4 B. Braun Beta-lactam and Beta-lactamase Inhibitors Products Offered
- 12.13 USantibiotics
- 12.13.1 USantibiotics Corporation Information
- 12.13.2 USantibiotics Description and Business Overview
- 12.13.3 USantibiotics Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
- 12.13.4 USantibiotics Beta-lactam and Beta-lactamase Inhibitors Products Offered
- 12.14 Qilu Pharmaceutical
- 12.14.1 Qilu Pharmaceutical Corporation Information
- 12.14.2 Qilu Pharmaceutical Description and Business Overview
- 12.14.3 Qilu Pharmaceutical Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
- 12.14.4 Qilu Pharmaceutical Beta-lactam and Beta-lactamase Inhibitors Products Offered
- 12.15 ACS Dobfar
- 12.15.1 ACS Dobfar Corporation Information
- 12.15.2 ACS Dobfar Description and Business Overview
- 12.15.3 ACS Dobfar Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
- 12.15.4 ACS Dobfar Beta-lactam and Beta-lactamase Inhibitors Products Offered
- 12.16 Nichi-Iko (Sagent)
- 12.16.1 Nichi-Iko (Sagent) Corporation Information
- 12.16.2 Nichi-Iko (Sagent) Description and Business Overview
- 12.16.3 Nichi-Iko (Sagent) Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
- 12.16.4 Nichi-Iko (Sagent) Beta-lactam and Beta-lactamase Inhibitors Products Offered
- 12.17 Antibiotice
- 12.17.1 Antibiotice Corporation Information
- 12.17.2 Antibiotice Description and Business Overview
- 12.17.3 Antibiotice Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
- 12.17.4 Antibiotice Beta-lactam and Beta-lactamase Inhibitors Products Offered
- 13 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES FACTORS ANALYSIS
- 13.1 Beta-lactam and Beta-lactamase Inhibitors Industry Trends
- 13.2 Beta-lactam and Beta-lactamase Inhibitors Market Drivers
- 13.3 Beta-lactam and Beta-lactamase Inhibitors Market Challenges
- 14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
- 14.1 Value Chain Analysis
- 14.2 Beta-lactam and Beta-lactamase Inhibitors Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
- 15 RESEARCH FINDINGS AND CONCLUSION
- 16 APPENDIX
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
- 16.3 Disclaimer
- List of Tables
- Table 1. Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
- Table 2. Penicillins of Current and Historical Uses
- Table 3. Cephalosporins of Current Clinical Utility or of Historical Interest
- Table 4. Major Manufacturers of Cephalosporins
- Table 5. Carbapenems of Current Clinical Utility
- Table 6. Major Manufacturers of Carbapenems
- Table 7. Carbapenems of Current Clinical Utility
- Table 8. Major Manufacturers of Monobactams
- Table 9. Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth Rate by Application,
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook